These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8435462)

  • 1. Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release.
    Apicella A; Cappello B; Del Nobile MA; La Rotonda MI; Mensitieri G; Nicolais L
    Biomaterials; 1993; 14(2):83-90. PubMed ID: 8435462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
    Nie SF; Liu H; Liu YL; Pan WS
    Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants.
    Zhang F; Meng F; Lubach J; Koleng J; Watson NA
    Eur J Pharm Biopharm; 2016 Aug; 105():97-105. PubMed ID: 27260202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water soluble drug delivery systems based on a non-biological bioadhesive polymeric system.
    Cappello B; Del Nobile MA; La Rotonda MI; Mensitieri G; Miro A; Nicolais L
    Farmaco; 1994 Dec; 49(12):809-18. PubMed ID: 7893338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities.
    Körner A; Larsson A; Andersson A; Piculell L
    J Pharm Sci; 2010 Mar; 99(3):1225-38. PubMed ID: 19718760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
    Nie SF; Tang H; Guo H; Pan WS
    Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study.
    Maggi L; Segale L; Torre ML; Ochoa ME; Conte U
    Biomaterials; 2002 Feb; 23(4):1113-9. PubMed ID: 11791914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights.
    Wu N; Wang LS; Tan DC; Moochhala SM; Yang YY
    J Control Release; 2005 Feb; 102(3):569-81. PubMed ID: 15681080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.
    Kim CJ
    Drug Dev Ind Pharm; 1998 Jul; 24(7):645-51. PubMed ID: 9876509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of poly(ethylene oxide) in controlled release tablet systems: a review.
    Ma L; Deng L; Chen J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):845-51. PubMed ID: 24001212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets.
    Li H; Hardy RJ; Gu X
    AAPS PharmSciTech; 2008; 9(2):437-43. PubMed ID: 18431663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release from compressed hydrophilic POLYOX-WSR tablets.
    Kim CJ
    J Pharm Sci; 1995 Mar; 84(3):303-6. PubMed ID: 7616368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity.
    Coutts-Lendon C; Koenig JL
    Appl Spectrosc; 2005 Aug; 59(8):976-85. PubMed ID: 16105205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
    Hong SI; Oh SY
    Int J Pharm; 2008 May; 356(1-2):121-9. PubMed ID: 18272308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system.
    Yang L; Fassihi R
    J Pharm Pharmacol; 2003 Oct; 55(10):1331-7. PubMed ID: 14607013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).
    Zhang F; McGinity JW
    Drug Dev Ind Pharm; 2000 Sep; 26(9):931-42. PubMed ID: 10914317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.
    Shojaee S; Nokhodchi A; Maniruzzaman M
    Drug Deliv Transl Res; 2017 Feb; 7(1):111-124. PubMed ID: 27873080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.